Skip to contentWILLIAMS DOUGLAS E — BIOGEN IDEC INC insider: 139 transactions · InsiderLensWILLIAMS DOUGLAS E
- EVP & President, R&D at Sana Biotechnology, Inc. · on record since Apr 11, 2023
- Director at ANADYS PHARMACEUTICALS INC · on record since Jun 2, 2006
- Director at ARRAY BIOPHARMA INC · on record since Nov 5, 2007
- Director at ZYMOGENETICS INC · on record since Dec 18, 2009
- Director at Oncothyreon Inc. · on record since Dec 7, 2009
- EVP Research & Development at BIOGEN IDEC INC · on record since Jan 20, 2011
- Director at SEATTLE GENETICS INC /WA · on record since Oct 2, 2003
- CSO, EVP R&D at SEATTLE GENETICS INC /WA · on record since Oct 2, 2003
- Director at Regulus Therapeutics Inc. · on record since Nov 8, 2012
- Director at Climb Bio, Inc. · on record since Jun 8, 2026
- Director at IRONWOOD PHARMACEUTICALS INC · on record since Jun 5, 2014
- Director at CalAmp Corp. · on record since Jun 12, 2026
- Executive VP R&D and CSO at ZYMOGENETICS INC · on record since Nov 2, 2004
- Director at Ovid Therapeutics Inc. · on record since May 4, 2017
- Director at Nuvation Bio Inc. · on record since Apr 6, 2021
- Director at Codiak BioSciences, Inc. · on record since Oct 20, 2020
- See Remarks at Codiak BioSciences, Inc. · on record since Oct 20, 2020
Insider trading activity of WILLIAMS DOUGLAS E
- Transactions on record
- 139
- since Oct 2, 2003
- Open-market buys
- 5
- $99.5K
- Open-market sells
- 9
- $3.8M
- Companies traded
- 13
- last filing Jun 12, 2026
Figures computed from official regulatory filings — methodology.
Companies where WILLIAMS DOUGLAS E has traded
- CalAmp Corp.2 tx · Jun 12, 2026
- Climb Bio, Inc.5 tx · Jun 8, 2026
- Sana Biotechnology, Inc.4 tx · Mar 8, 2024
- Codiak BioSciences, Inc.18 tx · $30.7K · Mar 30, 2023
- Ovid Therapeutics Inc.7 tx · $32.5K · May 18, 2021
- IRONWOOD PHARMACEUTICALS INC6 tx · Apr 3, 2019
- Regulus Therapeutics Inc.5 tx · Jun 3, 2016
- BIOGEN IDEC INC42 tx · $8.5M · Jun 22, 2015
- Oncothyreon Inc.9 tx · $49.8K · Jun 14, 2013
- ARRAY BIOPHARMA INC
Track record of WILLIAMS DOUGLAS E
Statistical track record
Free- Open-market buys
- 5
- Last buy
- Aug 14, 2018
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of WILLIAMS DOUGLAS E
Co-insiders of WILLIAMS DOUGLAS E
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $15.4K · Nov 8, 2010
LAMPERT MARK NARRAY BIOPHARMA INC +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 12, 2026 | AwardD | 28,000 | 0.00 USD | $0 | SEC |
| Jun 8, 2026 | AwardD | 40,000 | 0.00 USD | $0 | SEC |
| Jun 5, 2025 | AwardD | 40,000 | 0.00 USD | $0 | SEC |
| Apr 1, 2025 | AwardD | 78,873 | 0.00 USD | $0 | SEC |
| Mar 19, 2025 | AwardD | 17,787 | 0.00 USD | $0 | SEC |
| Nov 12, 2024 | AwardD | 20,000 | 0.00 USD | $0 | SEC |
| Nov 12, 2024 | AwardD | 6,291 | 0.00 USD | $0 | SEC |
| Mar 8, 2024 | AwardD | 301,875 | 0.00 USD | $0 | SEC |
| Mar 8, 2024 | AwardD | 67,083 | 0.00 USD | $0 | SEC |
| Nov 3, 2023 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Apr 11, 2023 | AwardD | 1,100,000 | 0.00 USD | $0 | SEC |
| Mar 30, 2023 | Sell | -41,667 | 0.18 USD | $7.5K | SEC |
| Feb 21, 2023 | Exercise | 22,969 | — | — | SEC |
| Feb 21, 2023 | Sell | -7,681 | 0.59 USD | $4.5K | SEC |
| Feb 21, 2023 | ExerciseD | -22,969 | 0.00 USD | $0 | SEC |
| Feb 21, 2023 | Sell | -7,112 | 2.21 USD | $15.7K | SEC |
| Feb 21, 2023 | Exercise | 22,969 | — | — | SEC |
| Feb 21, 2023 | ExerciseD | -22,969 | 0.00 USD | $0 | SEC |
| Jan 26, 2023 | AwardD | 465,000 | 0.00 USD | $0 | SEC |
| Jan 23, 2023 | ExerciseD | -13,667 | 0.00 USD | $0 | SEC |
| Jan 23, 2023 | Sell | -5,075 | 0.58 USD | $2.9K | SEC |
| Jan 23, 2023 | Exercise | 13,667 | — | — | SEC |
| Feb 18, 2022 | AwardD | 91,875 | 0.00 USD | $0 | SEC |
| Feb 18, 2022 | AwardD | 61,250 | 0.00 USD | $0 | SEC |
| Jan 21, 2022 | AwardD | 200,000 | 0.00 USD | $0 | SEC |